These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24339913)

  • 1. HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
    Gijsbers EF; Feenstra KA; van Nuenen AC; Navis M; Heringa J; Schuitemaker H; Kootstra NA
    PLoS One; 2013; 8(12):e81235. PubMed ID: 24339913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
    Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
    J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
    Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
    Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein.
    Prado JG; Honeyborne I; Brierley I; Puertas MC; Martinez-Picado J; Goulder PJ
    J Virol; 2009 Jan; 83(2):1018-25. PubMed ID: 18945768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
    Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
    J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
    Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
    J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
    Martinez-Picado J; Prado JG; Fry EE; Pfafferott K; Leslie A; Chetty S; Thobakgale C; Honeyborne I; Crawford H; Matthews P; Pillay T; Rousseau C; Mullins JI; Brander C; Walker BD; Stuart DI; Kiepiela P; Goulder P
    J Virol; 2006 Apr; 80(7):3617-23. PubMed ID: 16537629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein.
    Boutwell CL; Rowley CF; Essex M
    J Virol; 2009 Mar; 83(6):2460-8. PubMed ID: 19109381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.
    Liu D; Zuo T; Hora B; Song H; Kong W; Yu X; Goonetilleke N; Bhattacharya T; Perelson AS; Haynes BF; McMichael AJ; Gao F
    Retrovirology; 2014 Nov; 11():101. PubMed ID: 25407514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
    Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
    J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
    Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T
    J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.
    Boutwell CL; Carlson JM; Lin TH; Seese A; Power KA; Peng J; Tang Y; Brumme ZL; Heckerman D; Schneidewind A; Allen TM
    J Virol; 2013 Apr; 87(7):3952-65. PubMed ID: 23365420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.